PT - JOURNAL ARTICLE AU - Taguchi, Katsunari AU - Saitoh, Minori AU - Sato, Shuichi AU - Asano, Masaharu AU - Michel, Martin C. TI - Effects of Tamsulosin Metabolites at <em>Alpha</em>-1 Adrenoceptor Subtypes DP - 1997 Jan 01 TA - Journal of Pharmacology and Experimental Therapeutics PG - 1--5 VI - 280 IP - 1 4099 - http://jpet.aspetjournals.org/content/280/1/1.short 4100 - http://jpet.aspetjournals.org/content/280/1/1.full SO - J Pharmacol Exp Ther1997 Jan 01; 280 AB - We have investigated the affinity and selectivity of tamsulosin and its metabolites, M1, M2, M3, M4 and AM1, at the tissue and the clonedalpha-1 adrenoceptor subtypes in the radioligand binding and the functional studies. In the radioligand binding studies, the compounds competed for [3H]prazosin binding to the rat liver and kidney alpha-1 adrenoceptors, with the rank order of potency tamsulosin ≈ M4 &gt; M1 &gt; M2 ≈ M3 ≫AM1 with the latter having a negligible affinity. All compounds differentiated cloned alpha-1 adrenoceptor subtypes with the rank order of potency of alpha-1A ≥alpha-1D &gt; alpha-1B, except for M4 which had the highest affinity for the alpha-1D adrenoceptor. The compounds also concentration-dependently antagonized phenylephrine-induced contractions in the rabbit aorta and prostate. The resulting apparent pA2 values were very similar to those at the cloned rat alpha-1A adrenoceptor. We conclude that most tamsulosin metabolites are high potency antagonists at the alpha-1 adrenoceptors and retain thealpha-1A over the alpha-1B adrenoceptor selectivity of tamsulosin. The American Society for Pharmacology and Experimental Therapeutics